PGT121
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PGT121, covering 2022-05-10 to 2026-01-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults [Phase 1, Phase 2]